scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.2008.16.6546 |
P8608 | Fatcat ID | release_6wg7vjx3xfa7tdpuyyassnrsk4 |
P932 | PMC publication ID | 4879715 |
P698 | PubMed publication ID | 18725647 |
P50 | author | Harlan M. Krumholz | Q28211478 |
Benjamin Smith | Q43144805 | ||
Sharon H. Giordano | Q55640731 | ||
David I. Rosenthal | Q57015055 | ||
Wendy A Woodward | Q61037731 | ||
Grace L Smith | Q61826360 | ||
Adam S Garden | Q90650674 | ||
Randal Weber | Q94950283 | ||
Kie-Kian Ang | Q112388051 | ||
P2093 | author name string | Thomas A Buchholz | |
P2860 | cites work | Development of a comorbidity index using physician claims data | Q30623996 |
Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study | Q33223549 | ||
Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study | Q33262846 | ||
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q34595917 | ||
Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation | Q34943713 | ||
Risk of cardiac death after adjuvant radiotherapy for breast cancer | Q35754003 | ||
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis | Q36584651 | ||
Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease | Q41194083 | ||
Trends in the in-hospital stroke rate following carotid endarterectomy in California and Maryland | Q44139499 | ||
Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation | Q46151934 | ||
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy | Q47340813 | ||
Cardiac morbidity of adjuvant radiotherapy for breast cancer. | Q53267369 | ||
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 | Q56532851 | ||
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck | Q56532861 | ||
Effectiveness of Radiation Therapy for Older Women With Early Breast Cancer | Q57304514 | ||
Effectiveness of Radiation Therapy in Older Women With Ductal Carcinoma In Situ | Q57304517 | ||
Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas | Q57618448 | ||
A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies | Q58890596 | ||
Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy | Q61652713 | ||
Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke | Q63365961 | ||
Radiosensitivity and sublethal damage repair in human umbilical cord vein endothelial cells | Q69025195 | ||
Factors affecting late mortality from heart disease after treatment of Hodgkin's disease | Q70508903 | ||
The incidence of cerebrovascular accidents in patients with pituitary adenoma | Q73090147 | ||
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer | Q74613855 | ||
Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years | Q77438110 | ||
Decreased risk of stroke among 10-year survivors of breast cancer | Q79334431 | ||
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer | Q79887212 | ||
Increased incidence of stroke in women with breast cancer | Q81362281 | ||
P433 | issue | 31 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebrovascular disease | Q3010352 |
adaptive radiation therapy | Q180507 | ||
head and neck cancer | Q1783924 | ||
head and neck carcinoma | Q18554836 | ||
neck cancer | Q18966654 | ||
P304 | page(s) | 5119-5125 | |
P577 | publication date | 2008-08-25 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy | |
P478 | volume | 26 |
Q56991525 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
Q89490251 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repre |
Q34046881 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres |
Q53060252 | Accelerated radiotherapy for T1 to T2 glottic cancer. |
Q36854835 | Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer |
Q41808619 | An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer |
Q34143555 | Angiographic features, collaterals, and infarct topography of symptomatic occlusive radiation vasculopathy: a case-referent study. |
Q61807631 | Cancer-associated stroke: Pathophysiology, detection and management (Review) |
Q44019172 | Cardiotoxicity and cancer therapy |
Q37831391 | Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B. |
Q40403410 | Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy |
Q44336992 | Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy. |
Q33823152 | Carotid dosimetry for T1 glottic cancer radiotherapy. |
Q36798863 | Carotid sparing intensity modulated radiotherapy on early glottic cancer: preliminary study |
Q54856446 | Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer. |
Q33913896 | Causes of death in long-term survivors of head and neck cancer |
Q37459664 | Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report. |
Q36846709 | Clinical application of computed tomography-guided (125)I seed interstitial implantation for head and neck cancer patients with unmanageable cervical lymph node metastases |
Q39668102 | Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials |
Q91813403 | Comparison of Radiation Therapy Alone and Chemotherapy Alone for Low-Grade Gliomas without Surgical Resection |
Q104285299 | Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis |
Q34368413 | Contraindicated use of bevacizumab and toxicity in elderly patients with cancer |
Q42519375 | Early changes in brain FDG metabolism during anticancer therapy in patients with pharyngeal cancer. |
Q33758766 | Effects of external irradiation of the neck region on intima media thickness of the common carotid artery |
Q48526535 | European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted |
Q48525600 | European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constitute |
Q37471378 | Evaluating the Primary Prevention of Ischemic Stroke of Oral Antithrombotic Therapy in Head and Neck Cancer Patients with Radiation Therapy |
Q43721313 | Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort |
Q42150719 | Head and neck contrast-enhanced CT for identification of internal carotid artery stenosis progression on the affected side after treatment for oral squamous cell carcinoma |
Q40064475 | Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer |
Q57304489 | Hypothyroidism in older patients with head and neck cancer after treatment with radiation: A population-based study |
Q42594520 | Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique |
Q35653751 | Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy |
Q50062341 | Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer |
Q35169306 | Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial |
Q90734684 | Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study |
Q37572750 | Management of head and neck cancer in elderly patients |
Q37925869 | Management of vascular complications of head and neck cancer |
Q39579824 | Neck dissection and stroke in patients with oral cavity cancer: A population-based cohort study |
Q96136205 | Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma |
Q37452747 | Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer |
Q38042861 | Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma |
Q90432012 | Radiation Matters of the Heart: A Mini Review |
Q38720780 | Radiation Toxicity to the Cardiovascular System. |
Q33523954 | Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. |
Q26858921 | Radiation-induced carotid artery stenosis: a comprehensive review of the literature |
Q41664883 | Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors |
Q37227986 | Risk of fatal cerebrovascular accidents after external beam radiation therapy for early-stage glottic laryngeal cancer |
Q90628325 | Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer |
Q33891615 | Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer |
Q41344390 | Safety of intravenous thrombolysis for acute ischaemic stroke including concomitant neoplastic disease sufferers - experience from Poland |
Q26864522 | Second malignant neoplasms and cardiovascular disease following radiotherapy |
Q35839993 | Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer |
Q92856815 | Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and Neck |
Q90178723 | Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors |
Q92970630 | Stroke Rate Increases Around the Time of Cancer Diagnosis |
Q48188439 | T1-2 glottic cancer treated with radiotherapy and/or surgery. |
Q40046174 | The Benefit of Adjuvant Radiation in Surgically-Treated T1-2 N1 Oropharyngeal Squamous Cell Carcinoma |
Q88505605 | The risk of carotid stenosis in head and neck cancer patients after radiation therapy |
Q38936006 | Treatment of Head and Neck Paragangliomas. |
Q40449236 | Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis. |
Q44650073 | Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischaemic risk of stroke: a national database, controlled cohort study |
Search more.